Get started
BBB

BIORETEC OY

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

BRETEC chart


Full chart

BRETEC upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪39.86 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.180 EUR
Net income (FY)
‪−3.79 M‬ EUR
Revenue (FY)
‪3.91 M‬ EUR
Shares float
‪11.96 M‬
Beta (1Y)
0.47

Employees


Employees (FY)
37
Change (1Y)
+9 +32.14%
Revenue / Employee (1Y)
‪116.52 K‬ EUR
Net income / Employee (1Y)
‪−113.02 K‬ EUR

About BIORETEC OY


Sector
Health Technology
Industry
Medical Specialties
CEO
Alan Donze
Website
bioretec.com
Headquarters
Tampere
Founded
1998
ISIN
FI4000480454
FIGI
BBG011J0CZC1
Bioretec Ltd. develops bioabsorbable and bioresorbable implants for pediatric and adult orthopaedics. It specializes in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The company's products include bioabsorbable nails, pins, and screws as well as bioresorbable magnesium implants. Bioretec was founded in 1998 and is headquartered in Tampere, Finland.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

BRETEC news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BRETEC is 1.960 EUR — it has decreased by −1.01% in the past 24 hours. Watch BIORETEC OY stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXHEX exchange BIORETEC OY stocks are traded under the ticker BRETEC.
BRETEC stock has risen by 4.81% compared to the previous week, the month change is a −11.71% fall, over the last year BIORETEC OY has showed a −14.78% decrease.
We've gathered analysts' opinions on BIORETEC OY future price: according to them, BRETEC price has a max estimate of 2.60 EUR and a min estimate of 2.60 EUR. Watch BRETEC chart and read a more detailed BIORETEC OY stock forecast: see what analysts think of BIORETEC OY and suggest that you do with its stocks.
BRETEC reached its all-time high on Mar 30, 2023 with the price of 3.750 EUR, and its all-time low was 1.245 EUR and was reached on Dec 29, 2022. View more price dynamics on BRETEC chart.
See other stocks reaching their highest and lowest prices.
BRETEC stock is 2.84% volatile and has beta coefficient of 0.47. Track BIORETEC OY stock price on the chart and check out the list of the most volatile stocks — is BIORETEC OY there?
Today BIORETEC OY has the market capitalization of ‪39.86 M‬, it has decreased by −8.21% over the last week.
Yes, you can track BIORETEC OY financials in yearly and quarterly reports right on TradingView.
BIORETEC OY is going to release the next earnings report on Feb 14, 2025. Keep track of upcoming events with our Earnings Calendar.
BRETEC net income for the last half-year is ‪−1.88 M‬ EUR, while the previous report showed ‪−1.71 M‬ EUR of net income which accounts for −9.94% change. Track more BIORETEC OY financial stats to get the full picture.
No, BRETEC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 37.00 employees. See our rating of the largest employees — is BIORETEC OY on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIORETEC OY EBITDA is ‪−3.57 M‬ EUR, and current EBITDA margin is −72.53%. See more stats in BIORETEC OY financial statements.
Like other stocks, BRETEC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIORETEC OY stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIORETEC OY technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIORETEC OY stock shows the sell signal. See more of BIORETEC OY technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.